Michinori Ogura

2PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Apr 10, 2024
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.

Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi

|Sep 03, 2021
Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study.

Christian Buske, Wojciech Jurczak, Juan-Manuel Sancho

Pageof 1

Frequent Collaborators

1 joint publications

Wojciech Jurczak

1 joint publications

Juan-Manuel Sancho

1 joint publications

Jin Seok Kim

1 joint publications

José-Ángel Hernández-Rivas

1 joint publications

Aliaksandr Prokharau

1 joint publications

SangJoon Lee

1 joint publications

Takashi Watanabe

1 joint publications

Dai Maruyama

1 joint publications

Kazuyuki Shimada

1 joint publications

Junya Kuroda

Frequent Collaborators

1 joint publications

Wojciech Jurczak

1 joint publications

Juan-Manuel Sancho

1 joint publications

Jin Seok Kim

1 joint publications

José-Ángel Hernández-Rivas

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on : Aug 23, 2024

1.1K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on : Apr 16, 2019

18.5K
See more related videos

Top Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on : Aug 23, 2024

1.1K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on : Apr 16, 2019

18.5K
See more related videos